Immuno-modulatory role of baicalin in atherosclerosis prevention and treatment: current scenario and future...

Area of Science:

• Cardiovascular Research
• Immunology
• Pharmacology

Background:

• Atherosclerosis (AS) is a chronic inflammatory disease and a major risk factor for cardiovascular events.
• Current treatments for AS have limitations, necessitating novel therapeutic strategies.
• Huangqin (Scutellaria baicalensis), a traditional Chinese medicine, possesses immunomodulatory properties relevant to AS.

Purpose of the Study:

• To review the immunomodulatory properties of baicalin, a key component of Huangqin.
• To elucidate the mechanisms by which baicalin impacts AS.
• To highlight baicalin's potential as a clinical therapy for atherosclerosis.

Main Methods:

• Literature review focusing on immunomodulatory effects of baicalin in atherosclerosis.
• Analysis of pharmacological activities including immune balance, antioxidant, and lipid metabolism.
• Synthesis of evidence on baicalin's role in AS onset and progression.

Main Results:

• Baicalin demonstrates significant immunomodulatory effects beneficial for AS.
• It exhibits antioxidant, anti-inflammatory, and lipid-regulating properties.
• Baicalin positively influences both the initiation and advancement of AS.

Conclusions:

• Baicalin possesses multifaceted pharmacological activities relevant to atherosclerosis.
• Its immunomodulatory mechanisms present a promising therapeutic avenue for AS.
• Baicalin holds potential for clinical translation as an alternative or supplementary treatment for AS.